{"id":954656,"date":"2026-04-24T16:18:41","date_gmt":"2026-04-24T20:18:41","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-announces-grants-of-inducement-awards-6\/"},"modified":"2026-04-24T16:18:41","modified_gmt":"2026-04-24T20:18:41","slug":"crescent-biopharma-announces-grants-of-inducement-awards-6","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-announces-grants-of-inducement-awards-6\/","title":{"rendered":"Crescent Biopharma Announces Grants of Inducement Awards"},"content":{"rendered":"<div class=\"mw_release\">\n<p>WALTHAM, Mass., April  24, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=K83gqgzNichzMFl7Nhqyun4hJTAH6z3yr9wtV9V7siYQxEUEMRWZ6Qzdm1wlZFVTMD_-ZMQL_-58DmSr0nGJI2P4F5U56C0JyQ77PU9W1LFh3E1mZOnNyRsCJ6IKACJoHrTwEZsUcFGs5NxjAHv3hIp9Hw4ZVjAsLEWNtCyYSjbYkWTVUbrJJfZZj4yJeovA44IFzsbI2n265UXmhDO91eGsdXTEgdFi3vSRjbRttFOBElxBUzTQSF4d7Ew17B5D-WLjSwUTi73iS4v7xRTCsg==\" rel=\"nofollow\" target=\"_blank\">Crescent Biopharma<\/a>, Inc. (\u201cCrescent\u201d or the \u201cCompany\u201d) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced\u00a0that the independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 12,525 shares of the Company\u2019s ordinary shares to two non-executive employees as equity inducement awards under the Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan, as amended (the \u201cInducement Plan\u201d). The options were approved on April 23, 2026 and were material to each employee&#8217;s acceptance of employment with Crescent, in accordance with Nasdaq Listing Rule 5635(c)(4).<\/p>\n<p>The options were granted with a 10-year term and an exercise price equal to $25.70, the closing price per share of Crescent\u2019s ordinary shares as reported by Nasdaq on April 23, 2026. The options granted to each employee shall vest and become exercisable as to one-fourth (1\/4th) of the shares subject to the respective options on the first anniversary of the employee\u2019s start date, and one-forty-eighth (1\/48th) of the shares subject to the respective options shall vest and become exercisable monthly thereafter, in each case, subject to continuous service with Crescent through the applicable vesting dates. The options are subject to the terms of the Inducement Plan and the terms and conditions of an option agreement covering the applicable grant.<\/p>\n<p>\n        <strong>About Crescent Biopharma\u00a0<\/strong>\n      <\/p>\n<p>Crescent Biopharma\u2019s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company\u2019s clinical-stage pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates (ADCs). By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies either as single agents or as part of combination regimens to treat a range of solid tumors. For more information, visit\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tGMPdNE0DBZI3puj-xJnEm2gcNy_6hO_Mv-pqVTBYv3wOufcJfRn73JjwrL3-MU98XbFkRpCjmj_lD7bRRsaZvT6Gaa1FEjQC_UFOGth32vDdemD-LgdoIgW4WiKMOOr\" rel=\"nofollow\" target=\"_blank\">www.crescentbiopharma.com<\/a> and follow the Company on\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yN7aIUV93p5SvH2snsPT6Q2Mp42b53mdTR_ckuO0mqd7dHwlZUq1VEdlt65Pm5-3ljVF_ZByIyM37EkWvzlFiW96dYrDU8BjwL9yLrEyLmDLeEtJ9EZ_upplxjQwAiFG\" rel=\"nofollow\" target=\"_blank\">LinkedIn\u202f<\/a>and\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=R2a4IPc8doATu3S3ni_p54MIbp0bKspcTjf5NuqIzbGxIC8B__vpUma_6H9Tjfsz0bZmLDMoA4gPeruNcfeMRg==\" rel=\"nofollow\" target=\"_blank\">X<\/a>.\u00a0<\/p>\n<p>\n        <strong>Contact<\/strong><\/p>\n<p>Amy Reilly<br \/>Chief Communications Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=It6QLYkBzOVQxeWK1iO3a2tlZHQ0Xecl9whdO8RZTBQeHWdvtY2sXTdPNeg9227UT5mxaBuNn4bZar77A62zf3B9TTkK9cqcaNQVtnQx0BJ9ZKSFdetuaxY7e6rAp0_yEqbhbFEfWHB719wZSrUHcw7-q2eJ8U_ms8OI17fwcefiTDWh2_cdi0yMxKmsZTk8gizCIP6oyykUR3S6xMKoBCX0KPoUHtJVSeEx7koXMTtnD1xGASAd898DT2yu1CYkIqkR4etBaP6ODF-lXlfA74yCFsp-qrI8nMBNsQEaD6b92-Jdkr3tZrZ3QvPZx75F13gilNZYjAif7aGNoqj8QQ==\" rel=\"nofollow\" target=\"_blank\">amy.reilly@crescentbiopharma.com<\/a><br \/>617-465-0586<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NjY0OSM3NTU0NzkzIzIyOTg0ODA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NzFiNzdkN2ItZTFhZi00ZTQxLTljOGMtN2U1ODQ1NWIzOGJkLTEzMTAwMzAtMjAyNi0wNC0yNC1lbg==\/tiny\/Crescent-Biopharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WALTHAM, Mass., April 24, 2026 (GLOBE NEWSWIRE) &#8212; Crescent Biopharma, Inc. (\u201cCrescent\u201d or the \u201cCompany\u201d) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced\u00a0that the independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 12,525 shares of the Company\u2019s ordinary shares to two non-executive employees as equity inducement awards under the Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan, as amended (the \u201cInducement Plan\u201d). The options were approved on April 23, 2026 and were material to each employee&#8217;s acceptance of employment with Crescent, in accordance with Nasdaq Listing Rule 5635(c)(4). The options were granted with a 10-year term and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-announces-grants-of-inducement-awards-6\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Crescent Biopharma Announces Grants of Inducement Awards&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-954656","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Crescent Biopharma Announces Grants of Inducement Awards - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-announces-grants-of-inducement-awards-6\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Crescent Biopharma Announces Grants of Inducement Awards - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass., April 24, 2026 (GLOBE NEWSWIRE) &#8212; Crescent Biopharma, Inc. (\u201cCrescent\u201d or the \u201cCompany\u201d) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced\u00a0that the independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 12,525 shares of the Company\u2019s ordinary shares to two non-executive employees as equity inducement awards under the Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan, as amended (the \u201cInducement Plan\u201d). The options were approved on April 23, 2026 and were material to each employee&#8217;s acceptance of employment with Crescent, in accordance with Nasdaq Listing Rule 5635(c)(4). The options were granted with a 10-year term and &hellip; Continue reading &quot;Crescent Biopharma Announces Grants of Inducement Awards&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-announces-grants-of-inducement-awards-6\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-24T20:18:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NjY0OSM3NTU0NzkzIzIyOTg0ODA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-announces-grants-of-inducement-awards-6\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-announces-grants-of-inducement-awards-6\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Crescent Biopharma Announces Grants of Inducement Awards\",\"datePublished\":\"2026-04-24T20:18:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-announces-grants-of-inducement-awards-6\\\/\"},\"wordCount\":337,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-announces-grants-of-inducement-awards-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5NjY0OSM3NTU0NzkzIzIyOTg0ODA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-announces-grants-of-inducement-awards-6\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-announces-grants-of-inducement-awards-6\\\/\",\"name\":\"Crescent Biopharma Announces Grants of Inducement Awards - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-announces-grants-of-inducement-awards-6\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-announces-grants-of-inducement-awards-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5NjY0OSM3NTU0NzkzIzIyOTg0ODA=\",\"datePublished\":\"2026-04-24T20:18:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-announces-grants-of-inducement-awards-6\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-announces-grants-of-inducement-awards-6\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-announces-grants-of-inducement-awards-6\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5NjY0OSM3NTU0NzkzIzIyOTg0ODA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5NjY0OSM3NTU0NzkzIzIyOTg0ODA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-announces-grants-of-inducement-awards-6\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Crescent Biopharma Announces Grants of Inducement Awards\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Crescent Biopharma Announces Grants of Inducement Awards - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-announces-grants-of-inducement-awards-6\/","og_locale":"en_US","og_type":"article","og_title":"Crescent Biopharma Announces Grants of Inducement Awards - Market Newsdesk","og_description":"WALTHAM, Mass., April 24, 2026 (GLOBE NEWSWIRE) &#8212; Crescent Biopharma, Inc. (\u201cCrescent\u201d or the \u201cCompany\u201d) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced\u00a0that the independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 12,525 shares of the Company\u2019s ordinary shares to two non-executive employees as equity inducement awards under the Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan, as amended (the \u201cInducement Plan\u201d). The options were approved on April 23, 2026 and were material to each employee&#8217;s acceptance of employment with Crescent, in accordance with Nasdaq Listing Rule 5635(c)(4). The options were granted with a 10-year term and &hellip; Continue reading \"Crescent Biopharma Announces Grants of Inducement Awards\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-announces-grants-of-inducement-awards-6\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-24T20:18:41+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NjY0OSM3NTU0NzkzIzIyOTg0ODA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-announces-grants-of-inducement-awards-6\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-announces-grants-of-inducement-awards-6\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Crescent Biopharma Announces Grants of Inducement Awards","datePublished":"2026-04-24T20:18:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-announces-grants-of-inducement-awards-6\/"},"wordCount":337,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-announces-grants-of-inducement-awards-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NjY0OSM3NTU0NzkzIzIyOTg0ODA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-announces-grants-of-inducement-awards-6\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-announces-grants-of-inducement-awards-6\/","name":"Crescent Biopharma Announces Grants of Inducement Awards - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-announces-grants-of-inducement-awards-6\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-announces-grants-of-inducement-awards-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NjY0OSM3NTU0NzkzIzIyOTg0ODA=","datePublished":"2026-04-24T20:18:41+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-announces-grants-of-inducement-awards-6\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-announces-grants-of-inducement-awards-6\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-announces-grants-of-inducement-awards-6\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NjY0OSM3NTU0NzkzIzIyOTg0ODA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NjY0OSM3NTU0NzkzIzIyOTg0ODA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-announces-grants-of-inducement-awards-6\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Crescent Biopharma Announces Grants of Inducement Awards"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/954656","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=954656"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/954656\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=954656"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=954656"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=954656"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}